Dr Delphine Courmier is a Health Economics Director at Amgen with the responsibility of the biosimilar portfolio in the HTA Center of Excellence as well as Global Health Economics for the oncology biosimilars.
Delphine joins from Baxter where she was Global Market Access lead for 2 hospital products global Franchises. Prior to this role, she worked in Market Access and Health Economics both in consulting and industry in pharma (Novartis, Ipsen) and medical devices (J&J) since 2010. Her earlier career was in R&D in material design for various industries. Her last R&D project before switching to Market Access was to develop semiconductor-based sensors for airborne pathogens.
Delphine has an MBA from London Business School, a Ph.D. in Computational Chemistry from the University of Ottawa, Canada, an MSc. and BSc. in Chemistry from Université Pierre et Marie Curie Paris 6, France and a European Market Access University Diploma from Université Claude Bernard Lyon 1, France.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October